UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Efficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Choi, Sang Ho; Cesar, Antoni; Snow, Timothy Arthur Chandos; Saleem, Naveed; Arulkumaran, Nishkantha; Singer, Mervyn; (2023) Efficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Infectious Diseases , 76 (4) pp. 683-691. 10.1093/cid/ciac615. Green open access

[thumbnail of CID-114413_R1_submitted.pdf]
Preview
Text
CID-114413_R1_submitted.pdf - Accepted Version

Download (2MB) | Preview

Abstract

BACKGROUND: Doxycycline has been recommended as a treatment option for non-severe community-acquired pneumonia (CAP) in adults. We sought to review the evidence for the efficacy of doxycycline in adult patients with mild-to-moderate CAP. METHODS: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) of doxycycline versus comparator to assess the clinical efficacy. The primary outcome was the clinical cure rate. Random effects model meta-analyses were used to generate pooled odds ratio (OR) and evaluate heterogeneity (I2). Risk of bias (RoB) and quality of evidence (QoE) were evaluated using the Cochrane Risk of Bias 2.0 tool and GRADE methods, respectively. RESULTS: We included six RCTs with 834 clinically evaluable patients. The trials were performed between 1984 and 2004. Comparators were three macrolides (roxithromycin, spiramycin, and erythromycin) and three fluoroquinolones (ofloxacin, fleroxacin, and levofloxacin). Four trials had an overall high RoB. The clinical cure rate was similar between the doxycycline and comparator groups (87.2% [381/437] vs. 82.6% [328/397]; OR 1.29 [95% CI: 0.73-2.28]; I2 = 30%; low QoE). Subgroup analysis of two studies with a low RoB showed significantly higher clinical cure rates in the doxycyline group (87.1% [196/225] vs. 77.8% [165/212]; OR 1.92 [95% CI: 1.15-3.21]; P = 0.01; I2 = 0%). Adverse event rates were comparable between the doxycycline and comparator groups. CONCLUSION: The efficacy of doxycycline was comparable to macrolides or fluoroquinolones in mild-to-moderate CAP and thus represents a viable treatment option. Considering the lack of recent trials, it warrants large-scale clinical trials.

Type: Article
Title: Efficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/cid/ciac615
Publisher version: https://doi.org/10.1093/cid/ciac615
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: doxycycline, pneumonia, macrolide, fluoroquinolone, meta-analysis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10162763
Downloads since deposit
261Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item